share_log

Wedbush Downgrades Atreca to Neutral, Lowers Price Target to $1

Benzinga ·  Aug 14, 2023 06:56

Wedbush analyst Robert Driscoll downgrades Atreca (NASDAQ:BCEL) from Outperform to Neutral and lowers the price target from $4 to $1.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment